Liste des publications 2013-2011 Robert, E., Vandamme, M

Liste des publications 2013-2011
Robert, E., Vandamme, M., Brullé, L., Lerondel, S., Le Pape, A., Sarron, V., Riès, D., Darny, T., Dozias, S.,
Collet, G., Kieda, C., Pouvesle, J.M.
Perspectives of endoscopic plasma applications.
Clinical Plasma Medicine, in press
Mura, S., Zouhiri, F., Lerondel, S., Maksimenko, A., Mougin, J., Gueutin, C., Brambilla, D., Caron, J.,
Sliwinski, E., Lepape, A., Desmaele, D. & Couvreur, P.
Novel Isoprenoyl Nanoassembled Prodrug for Paclitaxel Delivery.
Bioconjug Chem, 2013, Vol. 24(11), pp. 1840-1849
Lavergne, M., Jourdan, M.-L., Blechet, C., Guyetant, S., Pape, A.L., Heuze-Vourc'h, N., Courty, Y., Lerondel,
S., Sobilo, J., Iochmann, S. & Reverdiau, P.
Beneficial role of overexpression of TFPI-2 on tumour progression in human small cell lung cancer.
FEBS Open Bio, 2013, Vol. 3, pp. 291-301
Lerondel, S. & Le Pape, A.
Bioluminescence Imaging in Rodents: When Light Illuminates Cancer Research
In Current Molecular Imaging, Bentham Science Publishers, ISSN: 2211-5544, 2013, Vol. 2, pp. 18-29
Al Nakouzi, N., Bawa, O., Le Pape, A., Lerondel, S., Gaudin, C., Opolon, P., Gonin, P., Fizazi, K. &
Chauchereau, A.
The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic
prostate cancer.
Neoplasia, 2012, Vol. 14(5), pp. 376-387
Brullé, L., Vandamme, M., Riès, D., Martel, E., Robert, E., Lerondel, S., Trichet, V., Richard, S., Pouvesle, J.M. & Le Pape, A.
Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc
orthotopic pancreatic carcinoma model.
PLoS One, 2012, Vol. 7(12), pp. e52653
Debray, D., Rainteau, D., Barbu, V., Rouahi, M., El Mourabit, H., Lerondel, S., Rey, C., Humbert, L.,
Wendum, D., Cottart, C.-H., Dawson, P., Chignard, N. & Housset, C.
Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane
conductance regulator deficiencies.
Gastroenterology, 2012, Vol. 142(7), pp. 1581-91.e6
Iochmann, S., Lerondel, S., Bléchet, C., Lavergne, M., Pesnel, S., Sobilo, J., Heuzé-Vourc'h, N., Le Pape, A. &
Reverdiau, P.
Monitoring of tumour progression using bioluminescence imaging and computed tomography scanning in a
nude mouse orthotopic model of human small cell lung cancer.
Lung Cancer, 2012, Vol. 77(1), pp. 70-76
Legigan, T., Clarhaut, J., Tranoy-Opalinski, I., Monvoisin, A., Renoux, B., Thomas, M., Le Pape, A., Lerondel,
S. & Papot, S.
The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors
in prodrug monotherapy.
Angew Chem Int Ed Engl, 2012, Vol. 51(46), pp. 11606-11610
Pesnel, S., Pillon, A., Créancier, L., Lerondel, S., Le Pape, A., Recher, C., Demur, C., Guilbaud, N. &
Kruczynski, A.
Optical imaging of disseminated leukemia models in mice with near-infrared probe conjugated to a monoclonal
antibody.
PLoS One, 2012, Vol. 7(1), pp. e30690
Vandamme, M., Robert, E., Lerondel, S., Pouvesle, J.-M. & Le Pape, A.
Non thermal plasmas, a new strategy in oncology?
Med Sci (Paris), 2012, Vol. 28(2), pp. 154-156
Vandamme, M., Robert, E., Lerondel, S., Sarron, V., Ries, D., Dozias, S., Sobilo, J., Gosset, D., Kieda, C.,
Legrain, B., Pouvesle, J.-M. & Pape, A.L.
ROS implication in a new antitumor strategy based on non-thermal plasma.
Int J Cancer, 2012, Vol. 130(9), pp. 2185-2194
Gaud, G., Iochmann, S., Guillon-Munos, A., Brillet, B., Petiot, S., Seigneuret, F., Touzé, A., Heuzé-Vourc'h,
N., Courty, Y., Lerondel, S., Gruel, Y. & Reverdiau, P.
TFPI-2 silencing increases tumour progression and promotes metalloproteinase 1 and 3 induction through
tumour-stromal cell interactions.
J Cell Mol Med, 2011, Vol. 15(2), pp. 196-208
Kruczynski, A., Vandenberghe, I., Pillon, A., Pesnel, S., Goetsch, L., Barret, J.-M., Guminski, Y., Le Pape, A.,
Imbert, T., Bailly, C. & Guilbaud, N.
Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system.
Invest New Drugs, 2011, Vol. 29(1), pp. 9-21
Lemarie, E., Vecellio, L., Hureaux, J., Prunier, C., Valat, C., Grimbert, D., Boidron-Celle, M., Giraudeau, B., le
Pape, A., Pichon, E., Diot, P., el Houfia, A. & Gagnadoux, F.
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety study.
J Aerosol Med Pulm Drug Deliv, 2011, Vol. 24(6), pp. 261-270
Maillet, A., Guilleminault, L., Lemarié, E., Lerondel, S., Azzopardi, N., Montharu, J., Congy-Jolivet, N.,
Reverdiau, P., Legrain, B., Parent, C., Douvin, D.-H., Hureaux, J., Courty, Y., De Monte, M., Diot, P.,
Paintaud, G., Le Pape, A., Watier, H. & Heuzé-Vourc'h, N.
The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.
Pharm Res, 2011, Vol. 28(9), pp. 2147-2156
Pesnel, S., Akkoul, S., Ledée, R., Leconge, R., Pillon, A., Kruczynski, A., Harba, R., Lerondel, S. & Le Pape,
A.
Use of an image restoration process to improve spatial resolution in bioluminescence imaging.
Mol Imaging, 2011, Vol. 10(6), pp. 446-452
Pesnel, S., Guminski, Y., Pillon, A., Lerondel, S., Imbert, T., Guilbaud, N., Kruczynski, A., Bailly, C. & Le
Pape, A.
99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.
Eur J Nucl Med Mol Imaging, 2011, Vol. 38(10), pp. 1832-1841
Pesnel, S., Pillon, A., Créancier, L., Guilbaud, N., Bailly, C., Kruczynski, A., Lerondel, S. & Le Pape, A.
Quantitation in bioluminescence imaging by correction of tissue absorption for experimental oncology.
Mol Imaging Biol, 2011, Vol. 13(4), pp. 646-652
Vandamme, M., Robert, E., Sobilo, J., Lerondel, S., Le Pape, A. & Pouvesle, J.-M.
Response of human glioma U87 xenografted on mice to non thermal plasma treatment.
Plasma Medicine, 2011, Vol. 1, pp. 27-43
Liste des brevets
Brevets Agents d’imagerie pour la médecine personnalisée et l’imagerie per-opératoire en cancérologie (coinventeurs CNRS : A. Le Pape – S. Lerondel)
-Dérivés fluorescents de cyanines polyamines en tant que sonde de diagnostic.
Brevet copropriété industrie/CNRS
Priorité : FR/24.11.10/FRA1059687
Extension internationale du 24/11/2011
-Complexe de technétium 99m en tant qu’outil de diagnostic in vivo des tumeurs cancéreuses.
Brevet copropriété industrie/CNRS
Priorité : FR/24.11.10/FRA1059690
Extension internationale du 24/11/2011
-Novel Imaging Agent: process for the preparation thereof and pharmaceutical composition containing the
same.
Brevet copropriété industrie/CNRS
Priorité : FR11/02213 du 13/07/2011
Extension internationale n°W02013007959 du 17/01/2013